Skip to main content

Want a detailed portfolio tracker?

Kura Oncology (KURA) P/E (2015 - 2026)

Kura Oncology (KURA) P/E from Nov 5, 2015 to Jul 21, 2026. The TTM Kura Oncology (KURA) P/E is -3.24. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kura Oncology (KURA)

YearP/EChange
2026-3.24+1.22%
2025-3.20-16.94%
2024-3.85-46.32%
2023-7.18+17.38%
2022-6.11-14.21%
2021-7.13-65.04%
2020-20.38+115.13%
2019-9.47+15.10%
2018-8.23-20.68%
2017-10.38+152.49%
2016-4.11-55.96%
2015-9.33N/A

Comparison Kura Oncology (KURA) P/E with competitors

Kura Oncology (KURA) P/E is -3.24.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.31%
FGENFibroGen Inc0.24-107.41%
CHRSCoherus Biosciences Inc0.85-126.19%
FBIOFortress Biotech Inc0.95-129.30%
ORMPOramed Pharmaceuticals Inc1.50-146.40%
AGENAgenus Inc3.01-192.90%
INVAInnoviva Inc3.15-197.36%
VXRTVaxart Inc3.55-209.57%
CRMDCorMedix Inc3.63-212.00%
CVACCureVac N.V.4.45-237.23%
GLPGGalapagos NV4.86-249.99%
SRPTSarepta Therapeutics Inc4.88-250.70%
ABEOAbeona Therapeutics Inc5.39-266.30%
ABUSArbutus Biopharma Corp5.60-272.73%
ZVRAZevra Therapeutics Inc5.89-281.73%
SPROSpero Therapeutics Inc6.23-292.26%
CGENCompugen Ltd6.31-294.90%
RIGLRigel Pharmaceuticals6.87-312.13%
SLXNSilexion Therapeutics Corp7.30-325.22%
OMEROmeros Corporation9.26-385.80%
AUPHAurinia Pharmaceuticals Inc9.58-395.87%
PLXProtalix BioTherapeutics Inc10.89-436.19%
ACADAcadia Pharmaceuticals Inc11.73-462.04%
TBPHTheravance Biopharma Inc12.26-478.51%
ADMAAdma Biologics Inc12.42-483.33%
HRMYHarmony Biosciences Holdings Inc13.82-526.61%
SABSSAB Biotherapeutics Inc14.14-536.36%
NAGENiagen Bioscience Inc14.82-557.41%
INCYIncyte Corp15.82-588.42%
REGNRegeneron Pharmaceuticals Inc15.86-589.47%
PBYIPuma Biotechnology Inc17.32-634.51%
CPRXCatalyst Pharmaceuticals Inc17.44-638.32%
EXELExelixis Inc17.54-641.37%
TGTXTG Therapeutics Inc18.97-685.45%
MDXGMimedx Group Inc20.55-734.42%
XOMAXOMA Royalty Corp22.87-806.12%
ARGXArgen X SE24.30-850.06%
CTMXCytomX Therapeutics Inc24.82-866.21%
XOMAOXOMA Royalty Corp25.34-882.37%
HALOHalozyme Therapeutics Inc25.62-890.98%
XOMAPXOMA Royalty Corp25.67-892.42%
VRTXVertex Pharmaceuticals Inc27.99-964.17%
RPRXRoyalty Pharma plc - Class A28.69-985.56%
SLNOSoleno Therapeutics Inc29.02-995.68%
ASNDAscendis Pharma A/S30.09-1028.72%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1270.31%
APLSApellis Pharmaceuticals Inc39.02-1304.55%
BMRNBiomarin Pharmaceutical Inc42.21-1403.04%
KRYSKrystal Biotech Inc45.34-1499.72%
ONCBeiGene Ltd69.54-2246.66%
PHARPharming Group N.V.75.03-2415.98%
TECHBio-Techne Corp101.96-3247.37%
VCELVericel Corp109.92-3493.18%
ALNYAlnylam Pharmaceuticals Inc117.96-3741.49%
GMABGenmab140.29-4430.66%
TLXTelix Pharmaceuticals Ltd162.15-5105.53%
CORTCorcept Therapeutics Inc212.86-6670.74%